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Abstract
Emptying the intracellular Ca2q stores by treatment with the endomembrane Ca2q-ATPase inhibitor thapsigargin
2q  . w 2qxactivates capacitative Ca entry CCE . This can be evidenced in fura-2-loaded cells by an increase of Ca or by ani
acceleration of Mn2q entry. Micromolar concentrations of arachidonic acid inhibited CCE induced by treatment with
thapsigargin in rat thymocytes and in human neutrophils. This inhibitory action was shared by other unsaturated fatty acids,
but not by the saturated arachidic acid nor by arachidonic acid methyl ester. The effect was not due to metabolites derived
 .from arachidonic acid since several non-metabolizable analogs were able to reproduce it. Phorbol dibutyrate PDB acted
 .similarly, suggesting that the inhibitory effect could be mediated by activation of protein kinase C PKC . However,
whereas the inhibition of CCE by PDB was reversed by treatment with the PKC inhibitor staurosporin, the inhibition by
arachidonic acid was not. We find that unsaturated fatty acids antagonized microsomal dealkylation of benzyl-resorufin, a
cytochrome P450-mediated activity, with the same specificity profile as for inhibition of CCE. These results are consistent
with previous proposals suggesting that a microsomal cytochrome P450 may be involved in the regulation of CCE. q 1997
Elsevier Science B.V.
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1. Introduction
In many cell types, emptying of the intracellular
calcium stores activates a plasma membrane pathway
w 2q x 2qAbbreviations: Ca , cytosolic Ca concentration; CCE,i
capacitative Ca2q entry; DHA, 5,6-dehydro-arachidonic acid;
ETI, 5,8,11-eicosatriynoic acid; ETYA, 5,8,11,14-eicosa-
tetraynoic acid; AME, arachidonic acid methyl ester; PDB, phor-
bol 12,13-dibutyrate; PKC, protein kinase C; AA, arachidonic
acid; EET, 5,6-epoxy-eicosatrienoic acid; AA-COCF3, arachi-
donyl trifluoromethylketone
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for Ca2q entry known as capacitative Ca2q entry
 w x. 2q CCE, 1 , store-operated Ca channels SOCCs,
w x. 2q 2q 2 or Ca release-activated Ca current I ,CRAC
w x.3 . CCE can be elicited by many physiological
agonists that act primarily by releasing Ca2q from the
intracellular stores, thus being responsible for much
2q w xof the agonist-induced Ca entry 4 . This delayed
Ca2q entry secondary to emptying of the stores is
essential for some of the physiological effects ob-
w xserved on stimulation by agonists 5 . Blockers of the
endoplasmic reticulum Ca2q ATPase, such as thapsi-
w xgargin 6 , also induce, after emptying of the stores
by Ca2q leak, CCE. It has been shown recently that
CCE can also be down-regulated by a mechanism
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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w xinvolving protein phosphorylation 7 , which can be
w xelicited either by several physiological agonists 8–11
w xor by phorbol esters 8,9 .
5,6-Epoxy-eicosatrienoic acid, an oxidation prod-
 .uct derived from arachidonic acid AA via P450
monooxygenases, has been proposed to activate CCE
w xin endothelial cells 12 . AA and other unsaturated
fatty acids have also been reported to promote Ca2q
w xentry in several cell types 13,14 , but these fluxes are
insensitive to inhibitors of CCE. On the other hand,
unsaturated fatty acids have been shown to antago-
nize agonist-induced Ca2q entry in T-lymphocytes
 w x.  w x.Jurkat line 15 and thyroid cells FRTL-5 line 16 .
Unsaturated fatty acids also antagonized thapsigar-
gin-induced Ca2q entry, suggesting that they may
w xinhibit CCE 16 . In the present paper, we have
studied the effects of AA and several AA analogs on
CCE induced by emptying the intracellular Ca2q
stores with thapsigargin in rat thymocytes and in
human neutrophils.
2. Materials and methods
w x w xRat thymocytes 17 and human neutrophils 4
were obtained and handled as described previously.
Cells were loaded with fura-2 by incubation with 4
mM fura-2rAM for 1 h at room temperature and
w 2qxCa and was measured as described previouslyi
w x4,17 . Briefly, cells were suspended at about 1%
cytocrit and the fluorescence excited at 340, 360 and
 .380 nm emission )510 nm was measured simulta-
w 2qxneously. Ca was estimated from the ratio ofi
w x 2qfluorescence excited at 340 and 380 nm 18 . Mn
2q w xwas used as a tracer for Ca entry 4,16 . The entry
of Mn2q was monitored by the quenching of fluores-
cence excited at 360 nm, which is insensitive to
w 2qx w xCa variations 19 . The standard incubationi
 .medium had the following composition in mM :
NaCl, 150; KCl, 5; MgCl , 1; CaCl , 1; glucose, 10;2 2
sodium-HEPES, 10, pH 7.4. The experiments with
thymocytes were performed at 258C and those with
neutrophils at 378C.
w x For preparation of microsomes 20 , rats Wistar,
.250 g were killed by decapitation and the liver was
homogenized in 5 vols. of a solution H containing
0.15 M KCl and 10 mM potassium-HEPES, pH 7.4
 .using a Potter homogenizer 400 rpm; 8 strokes .
After a 15-min centrifugation at 17 000=g and 48C,
the supernatant was recovered and centrifuged at
100 000=g during 60 min at 48C. The pellet was
resuspended in 0.5 vols. of solution H 13 mg pro-
.teinrml and stored at y808C. For measurements of
dealkylase activity, microsomes were diluted to 0.2
mg proteinrml in 0.1 M TrisrHCl buffer containing
50 mM NADPH and the assay was started by adding
0.5 mM 7-benzylresorufin. The activity was moni-
tored by the increase of fluorescence 530 nm excita-
. w xtion, 585 nm emission at room temperature 21 .
Arachidonic acid was obtained from Menarini Di-
agnostici, Firenze, Italy. Staurosporin, phorbol
 .12,13-dibutyrate PDB , miconazole, arachidic, 11-
eicosenoic, 11,14-eicosadienoic and 8,11,14-eicosa-
 .trienoic acids all cis forms and arachidonic acid
 .methyl ester AME were from Sigma, Madrid, Spain.
 .5,6-Dehydro-arachidonic acid DHA , 5,8,11-eico-
 .satriynoic acid ETI and 5,8,11,14-eicosatetraynoic
 .acid ETYA were from Cascade Biochem Ltd.,
Reading, UK. Thapsigargin and arachidonyl trifluo-
 .romethylketone AA-COCF3 were from Cal-
biochem, La Jolla, CA, USA. Other reagents were
obtained either from Sigma or from E. Merck, Darm-
stadt, Germany.
3. Results
3.1. Arachidonic acid has a dual effect on Ca2q
entry
Fig. 1 shows the effects of arachidonic acid on
w 2qx  . 2qCa upper panels and on the entry of Mni
 . 2q w xlower panels , an index of Ca entry 17,19 , in rat
thymocytes. The effects of two different concentra-
tions, 5 and 50 mM, are shown. As described previ-
w xously in several cell types 13 , the higher concentra-
w 2qx  .tion of AA increased Ca Fig. 1A , and this wasi
due to increased Ca2q entry, as shown by the acceler-
2q  .ation of Mn entry Fig. 1C . The smaller concen-
tration of AA had apparently little or no effect Fig.
. 2q1A,C . Stimulation of Ca entry by AA was ob-
served at concentrations above 20 mM and was maxi-
 .mal at 50–60 mM results not shown . This concen-
tration-dependence is similar to the one reported pre-
w xviously for platelets 13 .
The right-hand panels in Fig. 1 illustrate the ef-
fects of AA in cells which had been previously
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w 2q x 2qFig. 1. Effects of arachidonic acid on Ca and on Mn entryi
 .in rat thymocytes. The effects in control A,C and in thapsigar-
 .gin-treated cells 200 nM, 5 min; B,D are shown. Arachidonic
acid was added to the cell suspension from a concentrated stock
 . 2q14 mM to give the concentrations shown. For Mn entry
measurements, 1 mM MnCl was added from a concentrated2
 .100 mM stock and the decrease of the fluorescence excited at
 .360 nm F was followed. Readings have been normalized to360
100% at the time of Mn2q addition.
treated with the endomembrane ATPase inhibitor
w xthapsigargin 6 . Thapsigargin treatment produced an
w 2qx  .immediate increase of Ca Fig. 1B , which is duei
to Ca2q leak from the intracellular Ca2q stores to the
cytosol. After a 2–3 min of treatment with thapsigar-
w 2qxgin, a plateau level with increased Ca is found ati
the steady-state. This reflects an increased Ca2q en-
try, due to activation of CCE, which is balanced by
increased Ca2q extrusion at the plasma membrane,
due to activation of plasma membrane Ca2q ATPase
w 2qx w xby the increased Ca 8,9 . Inhibition of CCE ati
w 2qxthis stage produces a decrease of Ca towardsi
levels near those found before treatment with thapsi-
w xgargin 8 . The addition of 5 mM AA to
thapsigargin-treated cells produced a decrease of
w 2qx  .Ca , suggesting an inhibition of CCE Fig. 1B .i
The action of AA on CCE was further investigated
by testing their effects on Mn2q entry in thapsigar-
gin-treated cells. We have previously shown that
emptying the intracellular Ca2q stores accelerates
2q w xMn entry by 10–50 times in rat thymocytes 17 .
Fig. 1D shows the effects of AA on thapsigargin-
treated cells. The smaller concentration of AA 5
. 2q mM inhibited the entry of Mn by 73% compare
.to ‘Control’, not treated with AA , confirming that
AA is able to block CCE. In contrast, the higher 50
.mM concentration of AA produced a further increase
w 2qx  . 2q  .of both Ca Fig. 1B and Mn entry Fig. 1D .i
Thus, AA has a dual effect on Ca2q entry in rat
thymocytes. At the higher concentrations, we confirm
the previously reported stimulation of Ca2q entry. At
concentrations below 20 mM, it produced an inhibi-
tion of CCE. The concentration-dependence of this
inhibition is illustrated in Fig. 2. Half-maximal inhi-
bition was obtained between 1 and 3 mM AA for
both, Mn2q and Ca2q entry. The inhibition of CCE
by AA was prevented by adding bovine serum albu-
 . min 3 mgrml to the incubation medium results not
.shown . The effect of arachidonic acid was greatly
dependent on cell density, becoming much more
active at the lower cell concentrations results not
.shown .
Fig. 2. Effects of different concentrations of arachidonic acid on
2q  . w 2q x  .Mn uptake A and on Ca B in thapsigargin-treatedi
thymocytes. Arachidonic acid concentrations, in mM, are indi-
w 2q xcated on the right. Ca is expressed as percent of the value ati
 .the time of arachidonic acid AA addition, 4 min after treatment
with thapsigargin for standardization purposes. This value was
 .497"19 nM mean"S.E.M.; ns13 in this experiment. Other
details as in Fig. 1.
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3.2. Substrate specificity for the inhibition of CCE
The effects of arachidonic acid and several arachi-
donic acid analogs, all tested at 5 mM, on CCE of rat
thymocytes are compared in Fig. 3. Both, the inhibi-
w 2qxtion of the Ca increase induced by thapsigargini
 . 2q open bars and the inhibition of Mn entry cross-
.hatched bars were measured. The saturated analog
arachidic acid had no effect. The effect of the mono-
unsaturated 11-eicosenoic acid was much weaker than
AA, and the di- and tri-unsaturated arachidic acid
derivatives had about the same effect as AA. Among
the AA analogs containing triple bonds, 5,6-
 .dehydro-arachidonic acid DHA and 5,8,11-
 .eicosatriynoic ETI had about the same effects as
 .AA and 5,8,11,14-eicosatetraynoic ETYA had con-
sistently a somewhat smaller effect than AA. Arachi-
 .donic acid methyl ester AME had no effect. A
non-metabolizable AA analog in which carboxylate
 .group is replaced by the COCF3 group AA-COCF3 ,
w xwidely used as phospholipase A inhibitor 22 , had2
no effect at 5 mM. When tested at 60 mM AA-COCF3
inhibited thapsigargin induced Mn2q entry by 55"
 .8% mean"S.E.M.; ns5 .
In human neutrophils, arachidonic acid also antag-
onized CCE induced by thapsigargin, although con-
Fig. 3. Effects of several arachidonic acid analogs on the increase
w 2q x  .of Ca induced by thapsigargin open bars and on the entryi
2q  .of Mn in thapsigargin-treated cells cross-hatched bars . All
the compounds were tested at 5 mM. Other details as in Fig. 1.
C20:0, arachidic acid; C20:1, cis-11-eicosenoic acid; C20:2, cis-
11,14-eicosadienoic acid; C20:3, cis-8,11,14-eicosatrienoic acid;
 .C20:4, cis-5,8,11,14-eicosatetraenoic acid arachidonic acid ;
DHA, 5,6-dehydroarachidonic acid; ETI, cis-5,8,11-eico-
satriynoic acid; ETYA, cis-5,8,11,14-eicosatetraynoic acid; AME,
arachidonic acid methyl ester. Each value is the average of 3–8
individual data. Vertical bars represent S.E.M.
Table 1
w 2q xInhibition of the increase of Ca induced by thapsigargini
 w 2q x . 2qD Ca and of Mn entry by arachidonic acid and otheri
related substances in human neutrophils
Compound Inhibition of Inhibition of
2q 2qw xD Ca Mn entryi
 .  .Arachidic acid 8"1 3 4" 2 3
 .  .11-Eicosenoic acid 4"5 3 y1" 9 3
 .  .8,11,14-Eicosatrienoic acid 60"1 4 53"12 4
 .  .Arachidonic acid 53"3 9 74" 7 11
 .  .Arachidonic acid methyl ester 13"1 3 y2"4 4
Concentrations were 15 mM. Values are given as percent inhibi-
tion mean"S.E.M.; the number of determinations is given in
.parentheses .
centrations about 3 times larger had to be used to
achieve the same effects as in rat thymocytes. As
with thymocytes, AA was more active at lower cell
 .densities results not shown . The effects AA several
w 2qx 2qAA analogs on the increase of Ca and on Mni
entry are shown in Table 1. The relative actions were
similar to those reported above for thymocytes, i.e.,
the saturated fatty acid had little effect, whereas the
unsaturated ones inhibited CCE. Blocking the carbox-
 .ylate group AME decreased the inhibitory effect.
3.3. The effect of arachidonic acid is not re˝ersed by
staurosporin
Unsaturated fatty acids have been reported to acti-
w xvate protein kinase C 23,24 . Treatment with phorbol
esters produces inhibition of CCE in human neu-
trophils, and this inhibition is relieved by the protein
w xkinase C inhibitor staurosporin 8 . This result is
confirmed in Fig. 4A–C. The right-hand panels in the
figure illustrate the effects of staurosporin on the
inhibition of CCE induced by AA. Staurosporin did
not prevent the inhibition of the thapsigargin-induced
w 2qx  .Ca increase Fig. 4D,E nor the inhibition of thei
2q  .acceleration of the Mn entry Fig. 4F . In 8 similar
experiments, staurosporin reverted the phorbol dibu-
 . w 2qxtyrate PDB -induced inhibition of the Ca in-i
 .crease from 68"2 to 21"2% mean"S.E.M. ,
whereas the inhibition by arachidonic was 53"3 and
48"3% with and without staurosporin, respectively.
Regarding to the inhibition of Mn2q entry the figures
were mean"S.E.M.; ns6; without and with stau-
.rosporin : PDB, 81"2 and 20"5%; arachidonic
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acid 74"7 and 73"9%, respectively. In rat thymo-
cytes, PDB had a very small effect on CCE. In any
case, the inhibition of CCE of thymocytes by AA was
not significantly modified by staurosporin results not
.shown .
3.4. Unsaturated fatty acids inhibit P450-mediated
dealkylase acti˝ity
ETYA has been reported to inhibit cytochrome
w xP450-mediated activity 25 and a wide series of
cytochrome P450 inhibitors were also blockers of
w xCCE 17,26,27 . We have assayed the effects of AA
and several related substances on the resorufin ether
dealkylase activity of rat liver microsomes, a cy-
w xtochrome P450-mediated activity 21 . Fig. 5A illus-
trates representative results. AA was strongly in-
 .Fig. 4. Comparison of the effects of staurosporin ST on the
inhibition of capacitative Ca2q entry induced by either phorbol
 .  .12,13-dibutyrate PDB or by arachidonic acid AA in human
neutrophils. The concentrations of thapsigargin, PDB and AA
and staurosporin were 200 nM, 100 nM, 15 mM and 200 nM,
respectively. The concentration of Mn2q was 0.2 mM. Other
details as in Fig. 1.
Fig. 5. Effects of fatty acids on benzylresorufin-dealkylase activ-
ity of rat liver microsomes. A: comparison of the effects of
 .  .arachidic C20:0 and arachidonic acid C20:4 , both at 15 mM,
 .on dealkylase activity. The effect of miconazole 10 mM is
shown for comparison. B: correlation between the effects of
 .several fatty acids same as in Fig. 3 and Table 2 on dealkylase
w 2q xactivity and on the increase of Ca induced by thapsigargin ini
rat thymocytes. Bars represent S.E.M. Line adjusted by the
minimum squares procedure.
hibitory, whereas arachidic acid had little effect. The
effect of the P450 inhibitor miconazole is also shown
for comparison. Table 2 compares the effects of
arachidonic acid and some arachidonic acid analogs
on the dealkylase activity. The parallel with the
effects on CCE is apparent compare to Fig. 3 and
.Table 1 . Fig. 5B shows the correlation for the in-
hibitory actions on Ca2q influx through CCE in rat
thymocytes and on microsomal dealkylase activity.
The correlation coefficient, r, was 0.87. Similarly,
the correlation coefficient for inhibition of Mn2q
entry through CCE and dealkylase activity was 0.76
 .results not shown .
Table 2
Effects of several fatty acids on 7-benzylresorufin-dealkylase
activity of rat liver microsomes
Compound % Inhibition
 .Arachidic acid 13"17 4
 .11-Eicosenoic acid 16" 5 5
 .11,14-Eicosadienoic acid 52"10 3
 .8,11,14-Eicosatrienoic acid 45" 5 4
 .  .Arachidonic acid 5,8,11,14 54" 7 5
 .  .5,6-Dehydroarachidonic acid DHA 65"15 2
 .  .5,8,11-Eicosatriynoic ETI 59" 6 3
 .  .5,8,11,14-Eicosatetraynoic ETYA 50"10 3
 .Arachidonic acid methyl ester 17" 7 5
All the compounds were tested at 15 mM, except DHA, which
was tested at 5 mM. Values are given as mean"S.E.M. The
number of determinations is given in parentheses.
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4. Discussion
The results shown here demonstrate that arachi-
donic acid, in addition to its previously described
2q w xCa -influx-stimulating effect 13 , is able, at lower
concentrations, to inhibit capacitative Ca2q entry in
rat thymocytes and in human neutrophils. In several
cell lines, the receptor-operated Ca2q influx is sec-
ondary to activation of CCE on emptying of the
2q w xintracellular Ca stores 4 . Therefore, our results
are consistent with and may help to explain previous
reports on inhibition of receptor-operated Ca2q influx
w xby unsaturated fatty acids 15,16 . It has been claimed
that the inhibition of Ca2q influx by fatty acids may
2q w xbe due to increased Ca extrusion 14,28,29 . The
experiments with Mn2q shown here demonstrate,
however, a direct inhibitory effect on Ca2q entry.
The inhibitory effect on CCE is not specific for
arachidonic acid, but it is shared by other unsaturated
analogs specially those containing more than two
.double or triple bonds , but not by the saturated ones.
The free carboxylate group is required. Surprisingly,
the substrate specificity profile for the inhibitory
effect is similar to the one reported before for the
Ca2q-influx stimulating effect of several fatty acids
w x13 , although the stimulatory effect requires a con-
w xcentration about 10 times larger 13 , see also Fig.
.1 . Since large amounts of arachidonic acid may be
produced on stimulation of phospholipase A by a2
wide variety of agonists, regulation of Ca2q influx by
fatty acids could have physiological and pathophysio-
logical relevance.
It has been recently proposed that production of
 .5,6-epoxy-eicosatrienoic acid EET , whose synthesis
from AA is catalyzed by a microsomal P450 mono-
oxygenases, is stimulated by emptying the Ca2q stores
and that EET stimulates CCE. Thus, EET might act
w xas the messenger for activation of CCE 12 . Our
results do not favor, in principle, this possibility
since, under this view, AA should not be expected to
inhibit, but to stimulate, CCE. It could be argued that
fatty acids or their derivatives may antagonize the
synthesis of EET and this possibility cannot be ex-
cluded. In any case, our results suggest that the
inhibitory effect is due to the fatty acid itself and not
to a metabolite derived from it, as we find that
several non-metabolizable AA analogs also inhibit
CCE. As a matter of fact, some of these analogs are
inhibitors of arachidonic acid metabolism. On the
other hand, we have shown before that neither cyclo-
 .oxygenase acetyl-salicylic acid, compound BW755C
nor lypooxygenase inhibitors compound BW755C,
.baicalein, caffeic acid, esculetin, phenidone prevent
w xCCE in rat thymocytes 17,26 . 14,15-Epoxyei-
cosatrienoic acid has been recently shown to produce
w xinhibition of CCE in human platelets 30 .
It has also been recently shown that activation of
PKC using phorbol esters produces inhibition of CCE
w xin human neutrophils 8 . Since unsaturated fatty
w xacids have been reported to activate PKC 23,24 it
could be proposed that the inhibition of CCE shown
here takes place by this mechanism. We find, how-
ever, that whereas the PKC inhibitor staurosporin was
able to prevent the inhibition of CCE produced by
phorbol ester, it had little or no effect on the inhibi-
tion produced by AA. This suggests that inhibition of
CCE by fatty acids do not take place via activation of
PKC. We have recently shown that the inhibition of
CCE of human neutrophils produced by the chemo-
w xtactic peptide fMLP 8 , which involves protein phos-
w xphorylation 7 , is not reverted by staurosporin either
w x8 . In addition, the appearance of inhibition of CCE
by phorbol ester and by fMLP during differentiation
of HL60 human leukemia cells towards granulocytes
w xshows a different time course 9 . This suggests that
protein kinases other than the C-type may down-regu-
late CCE. Thus, the possibility that unsaturated fatty
acids may act through other protein kinases may not
be excluded.
On the basis of the inhibitory effects of a large
series of cytochrome P450 antagonists, we have pro-
posed that the link between emptying of the intra-
cellular Ca2q stores and activation of CCE may be a
metabolite generated by a microsomal cytochrome
P450 whose activity would be stimulated by the
w 2qx w xdecrease of Ca inside the stores 17,26 . Thisi
hypothesis has been severely criticized on the basis
wof what we consider as circumstantial evidence 31–
x33 . ETYA, one of the arachidonic acid analogs
tested here, had been previously reported to inhibit
w xP450-mediated activity 25 . We now find that the
same fatty acids that antagonize CCE also inhibit rat
liver microsomal benzylresorufin-dealkylase, a
P450-mediated activity. This might be casual, but
certainly it is consistent with the P450 hypothesis.
We find other similarities among the unsaturated
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fatty acids tested here and other P450 inhibitors
shown before to inhibit CCE. For example, many of
them are lypooxygenase inhibitors ETYA, ETI or
DHA among arachidonic acid derivatives, nordihy-
droguaiaretic, gossypol or compound AA861 among
w x.P450 inhibitors 17,26 . On the other hand, the abil-
2q  2q.ity to increase Ca and Mn influx found for the
fatty acids at the higher concentrations Fig. 1 and
w x.13 has also been reported for several P450 in-
hibitors when used at 5–10 times the IC for inhibi-50
tion of CCE econazole, miconazole, nordhydrogua-
w xxiaretic acid, compound SKF525A, gossypol 27 . In
all the cases the Ca2q entry is blocked by Ni2q. Of
course, these results are only phenomenological evi-
dence in favor of the P450 hypothesis for the regula-
tion of CCE. On the other hand, the P450 family is so
w xwide and with such different functions 34,35 that,
without further concretion, it is difficult to valorate
adequately the arguments for and against this hypoth-
esis. Therefore, it seems reasonable to wait for direct
evidence on the mechanism linking the intracellular
Ca2q stores and CCE before giving a definitive
interpretation to the inhibition by P450 inhibitors and
by unsaturated fatty acids.
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